AM

Amphastar Pharmaceuticals IncNASDAQ AMPH Stock Report

Last reporting period 30 Jun, 2024

Updated 14 Nov, 2024

Last price

Market cap $B

2.307

Small

Exchange

XNAS - Nasdaq

View Section: Eyestock Rating

Amphastar Fair Value

AM

The fair market value of AMPH stock is 70.37 USD. Relative to the market price of 45.28 USD Amphastar is undervalued by 55.4%

Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.

Fair Relative Value

Greatly undervalued 55.4%
70.37 USD
AMPH Fair Value
45.28 USD
Market price of AMPH

Amphastar Valuation

Current AMPH share ticker price is 45.28 USD.

The fair value level of 70.37 USD can be considered as an effective entry point for long-term investors to start investing in AMPH stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.

Price chart is not available

1y
3y
5y
All time
Market price

Current market price

Fair value

Current price is 55% lower its fair value

Min value

Current price is 8% lower its minimum value

Max value

Current price is 1396% lower its maximum value

14.11.2024

Market price:

* Eyestock is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on eyestock.io represent a recommendation to buy or sell a security.

AMPH stock is greatly undervalued

It means the current price may concern as a Low Risk Entry Point

Amphastar Pharmaceuticals Inc Stock Valuation Calculator

How do we value a stock?

As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.

1

Maximum P/E over 5 years

197.22

2

Median P/E over 5 years

20.48

3

Minimum P/E over 5 years

14.24

4

Earning per share (last 12 months)

3.44 USD

Maximum value

1

x

4

=

677.6 USD

Fair value

2

x

4

=

70.37 USD

Minimum value

3

x

4

=

48.91 USD

Amphastar Pharmaceuticals Inc price metrics

22.77

Annual return (geometric mean)

42.12

Risk (standard deviation) of returns

β

0.79

Beta (volatility compared to market)

It means that AMPH stock is less volatile than the broader market

Discover Undervalued Companies


View Section: Profitability